Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCGR | P47871 | 12/20 | 0.57 |
| ▸ | ADCY6 | O43306 | 6/20 | 0.57 |
| ▸ | ADCY3 | O60266 | 6/20 | 0.57 |
| ▸ | ADCY9 | O60503 | 6/20 | 0.57 |
| ▸ | ADCY5 | O95622 | 6/20 | 0.57 |
| ▸ | ADCY8 | P40145 | 6/20 | 0.57 |
| ▸ | ADCY7 | P51828 | 6/20 | 0.57 |
| ▸ | ADCY2 | Q08462 | 6/20 | 0.57 |
| ▸ | ADCY1 | Q08828 | 6/20 | 0.57 |
| ▸ | ADCY4 | Q8NFM4 | 6/20 | 0.57 |
| ▸ | NR1H4 | Q96RI1 | 3/20 | 0.52 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.52 |
| ▸ | ESRRG | P62508 | 4/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | ESRRB | O95718 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2655298 | 0.91 | FFAR1 (0.49) | GCGRADCY6ADCY3ADCY9ADCY5 | |
| SCHEMBL2657987 | 0.91 | NR1H4 (0.59) | GCGRADCY6ADCY3ADCY9ADCY5 | |
| SCHEMBL2654908 | 0.86 | GCGR (0.46) | GCGRADCY6ADCY3ADCY9ADCY5 | |
| SCHEMBL2656549 | 0.86 | CA1 (0.48) | NR1H4EPHX2 | |
| SCHEMBL2655270 | 0.83 | GCGR (0.53) | GCGRADCY6ADCY3ADCY9ADCY5 | |
| SCHEMBL2657509 | 0.82 | ROCK2 (0.41) | GCGRADCY6ADCY3ADCY9ADCY5 | |
| SCHEMBL2655282 | 0.81 | GCGR (0.51) | GCGREPHX2 | |
| SCHEMBL2657309 | 0.80 | ESRRG (0.53) | GCGRADCY6ADCY3ADCY9ADCY5 | |
| SCHEMBL2654353 | 0.80 | NR1H4 (0.54) | GCGRADCY6ADCY3ADCY9ADCY5 | |
| SCHEMBL2653593 | 0.79 | NR1H4 (0.64) | GCGRADCY6ADCY3ADCY9ADCY5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1951661-A2 | GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES | ELI LILLY AND COMPANY (US) | 2008-08-06 | — | — | EP | claimed |
| WO-2007106181-A2 | GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES | ELI LILLY AND COMPANY (US) | 2007-09-20 | — | — | WO | claimed |
| EP-1951661-A2 | GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES | ELI LILLY AND COMPANY (US) | 2008-08-06 | — | — | EP | disclosed |
| WO-2007106181-A2 | GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES | ELI LILLY AND COMPANY (US) | 2007-09-20 | — | — | WO | disclosed |